[1]
Rothstein DM, Rifamycins, Alone and in Combination. Cold Spring Harbor perspectives in medicine. 2016 Jul 1; [PubMed PMID: 27270559]
[2]
Howard P,Twycross R,Grove G,Charlesworth S,Mihalyo M,Wilcock A, Rifampin (INN Rifampicin). Journal of pain and symptom management. 2015 Dec; [PubMed PMID: 26432572]
[3]
Mieras LF,Taal AT,van Brakel WH,Cambau E,Saunderson PR,Smith WCS,Prakoeswa CRS,Astari L,Scollard DM,do Nascimento DC,Grosset J,Kar HK,Izumi S,Gillini L,Virmond MCL,Sturkenboom MGG, An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP . BMC infectious diseases. 2018 Oct 5; [PubMed PMID: 30290790]
[4]
Campbell EA,Korzheva N,Mustaev A,Murakami K,Nair S,Goldfarb A,Darst SA, Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell. 2001 Mar 23; [PubMed PMID: 11290327]
[5]
McClure WR,Cech CL, On the mechanism of rifampicin inhibition of RNA synthesis. The Journal of biological chemistry. 1978 Dec 25; [PubMed PMID: 363713]
[6]
Schulz W,Zillig W, Rifampicin inhibition of RNA synthesis by destabilisation of DNA-RNA polymerase-oligonucleotide-complexes. Nucleic acids research. 1981 Dec 21; [PubMed PMID: 6174947]
[7]
Wietholtz H,Marschall HU,Sjövall J,Matern S, Stimulation of bile acid 6 alpha-hydroxylation by rifampin. Journal of hepatology. 1996 Jun; [PubMed PMID: 8835747]
[10]
Treatment of tuberculosis. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2003 Jun 20; [PubMed PMID: 12836625]
[12]
Tran JH,Montakantikul P, The safety of antituberculosis medications during breastfeeding. Journal of human lactation : official journal of International Lactation Consultant Association. 1998 Dec; [PubMed PMID: 10205455]
[13]
Khurana S,Singh P, Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials. Liver international : official journal of the International Association for the Study of the Liver. 2006 Oct; [PubMed PMID: 16953834]
[15]
Niemi M,Backman JT,Fromm MF,Neuvonen PJ,Kivistö KT, Pharmacokinetic interactions with rifampicin : clinical relevance. Clinical pharmacokinetics. 2003; [PubMed PMID: 12882588]
[16]
Saukkonen JJ,Cohn DL,Jasmer RM,Schenker S,Jereb JA,Nolan CM,Peloquin CA,Gordin FM,Nunes D,Strader DB,Bernardo J,Venkataramanan R,Sterling TR, An official ATS statement: hepatotoxicity of antituberculosis therapy. American journal of respiratory and critical care medicine. 2006 Oct 15; [PubMed PMID: 17021358]
[17]
Sridhar A,Sandeep Y,Krishnakishore C,Sriramnaveen P,Manjusha Y,Sivakumar V, Fatal poisoning by isoniazid and rifampicin. Indian journal of nephrology. 2012 Sep; [PubMed PMID: 23326053]